metoclopramide has been researched along with Agoraphobia in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anfinson, TJ | 1 |
| Kluge, M | 1 |
| Schüssler, P | 1 |
| Steiger, A | 1 |
2 other studies available for metoclopramide and Agoraphobia
| Article | Year |
|---|---|
Akathisia, panic, agoraphobia, and major depression following brief exposure to metoclopramide.
Topics: Agoraphobia; Akathisia, Drug-Induced; Depressive Disorder; Humans; Male; Metoclopramide; Middle Aged | 2002 |
Persistent generalized anxiety after brief exposure to the dopamine antagonist metoclopramide.
Topics: Adult; Agoraphobia; Antiemetics; Dopamine Antagonists; Female; Gastrointestinal Diseases; Humans; Me | 2007 |